A comprehensive study reveals patient demographics, treatment outcomes, and significant adverse event associations in cancer therapies across large datasets.
This study evaluated data from 44,502 unique patients, with a median follow-up of 1,874 days. The majority of patients were older men with initial cancer diagnosis and independent in daily activities. A total of 175,624 diagnosis records and over 15 million prescription orders were analyzed. The results highlighted significant hazards for adverse events linked to ...
